.Halia Therapeutics yesterday announced the opening of its new 20,000 square foot headquarters located at The Summit, on 3900 North Traverse Mountain Blvd., in Lehi, Utah. #BioHive

prnewswire.com/news-releases/…

Leah Frautschy is the VP, Clinical Manufacturing at Denali Therapeutics. In this #BioHive Talk, she discusses the significance of cultivating diverse teams and provides insights into the strategies for fostering such teams within your organization.

📺 youtu.be/NnwFqN8chjc

Leah Frautschy is the VP, Clinical Manufacturing at Denali Therapeutics. In this #BioHive Talk, she discusses the significance of cultivating diverse teams and provides insights into the strategies for fostering such teams within your organization.

📺 youtu.be/NnwFqN8chjc

Thank you SLC Economic Development for helping connect the #BioHive to our incredible educators in #SaltLakeCity ! 👏

Great work, Seek Labs, Recursion and Checkerspot !

Together we can do amazing things. 📈

Predicting protein targets for ~36 billion compounds takes a massive team effort. We sat down with our VP of #digitalchemistry Stephen MacKinnon to learn more about what went into accomplishing this feat.

Read more: recursion.com/news/a-deep-di…

#biotech #artificialintelligence …

.Myriad Genetics and Intermountain Health are teaming up to provide access to ComboMATCH trials! 👏

Backed by National Cancer Institute & ECOG-ACRIN Cancer Research Group, these trials strive to uncover effective anti-cancer drug combinations. #biohive #therapeutics #clinicaltrials #utah

buff.ly/3DQ3TAR

Discover why quality control is essential for your health care startup on August 23!

Led by Lars Mouritsen and sponsored by Avendium, join Altitude Lab to gain valuable insights and strategies for FDA approval and successful product launch. 🚀

Register: bit.ly/44XZ7wE

Halia Therapeutics announced today the completion of enrollment for its phase I clinical trial of HT-6184 for chronic inflammation.

See the news release here: prn.to/45jmv8k

Congratulations to the #lifescience industry professionals that received a 2023 Utah Business HR Achievement Award!

Britt McPartland, SHRM-SCP, Senior Director, People & Site Operations, Pathos

Mike Voigt, Chief Human Resources Officer, Merit Medical

utahbusiness.com/events/hr-achi…

Alucent Biomedical announced that the FDA granted an Investigational Device Exemption (IDE) for a U.S. clinical study of AlucentNVS, a unique light-activated, drug-coated balloon catheter technology.

#biohive #ide #vasculardisease

Read more: buff.ly/45fOCoz

Exciting new partnership in the #BioHive !

Quansys Biosciences and michaeljfox.org have partnered to accelerate Parkinson’s disease research.

Read more: buff.ly/3QGNman

#utah #parkinsonsdisease #parkinsonsresearch #therapeutics

.@UPIVOTCenter is hosting the inaugural Innovation Awards on Monday, October 2 to recognize the incredible researchers at the U who are working to translate their research into technologies that benefit the public.

Nominate a researcher by 8/1!

buff.ly/3Y9pxJP

With the unveiling of Valence Labs (Valence Labs), our new #ML research center, we are doubling down on our commitment to open science by dedicating this team to building the ML community through data, tool and infrastructure releases. And we are kicking things off by committing…

Inherent Biosciences research paper, 'Tissue-specific DNA methylation variability and its potential clinical value,' was published by Frontiers in Genetics, a major journal that publishes rigorously peer-reviewed research on genes and genomes.

buff.ly/3KcTAdH

A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by the U.S. FDA.

This milestone marks the first time that a novel medical device has received an FDA 510(k) clearance in University of Utah history.

buff.ly/44TXD6M

There is an industry shift happening right now: from #biotech to #techbio .

Chris Gibson spoke with BNN Bloomberg about how our partnership with NVIDIA and recent acquisitions of Cyclica and Valence Labs are powering the #techbio revolution.

Watch⬇️
bnnbloomberg.ca/video/i-think-…

MyRisk® Hereditary Cancer Test with RiskScore® now incorporates breast density using TCv8 to provide patients & providers with a more comprehensive look at their five-year and remaining lifetime risk for #breastcancer . Learn more: fal.cn/3A8zX

BYU researcher Justina Tavana is breaking barriers in Alzheimer's research among Pacific Islanders as she aims to include underrepresented communities in the fight against the disease. #alzheimersresearch #healthequity #biohive #utah

buff.ly/3KaL3Ig